• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性多发性硬化症发病年龄的预测。

Anticipation of age at onset in familial multiple sclerosis.

机构信息

Neurology Department, Multiple Sclerosis Unit, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain.

出版信息

Eur J Neurol. 2010 Apr;17(4):572-5. doi: 10.1111/j.1468-1331.2009.02870.x. Epub 2009 Dec 7.

DOI:10.1111/j.1468-1331.2009.02870.x
PMID:20002735
Abstract

BACKGROUND AND OBJECTIVE

Anticipation of age at onset in the younger generations is a widely known characteristic of many diseases with genetic inheritance. This study was performed to assess whether there is anticipation of age at onset in younger generations of familial multiple sclerosis (MS) in a Spanish population and to compare clinical characteristics of familial and sporadic MS.

METHODS

We studied a cohort of 1110 patients diagnosed with MS and followed-up in our MS Unit. Patients were considered as familial MS if they had in their family at least one relative of first or second degree diagnosed with MS. Otherwise, patients were considered to have sporadic MS. We compared the age at onset between relatives from different generations, and we also compared the age at onset of familial and sporadic MS.

RESULTS

A lower age at onset in the younger generations was found (median 22 years vs. 30 years, P < 0.001) and a significant lower age at onset of the disease in familial MS comparing to sporadic MS (median 25 years vs. 29 years, P = 0.042).

CONCLUSIONS

There is an anticipation of the age at onset of MS in the younger generations of patients with familial MS. There is also a lower age at onset in familial versus sporadic MS.

摘要

背景与目的

在具有遗传因素的许多疾病中,年轻一代发病年龄的预期是一个众所周知的特征。本研究旨在评估西班牙人群中家族性多发性硬化症(MS)年轻一代是否存在发病年龄的提前,并比较家族性和散发性 MS 的临床特征。

方法

我们研究了在我们的 MS 病房接受诊断和随访的 1110 名 MS 患者的队列。如果患者的直系或旁系亲属中至少有一名被诊断为 MS,则将其视为家族性 MS。否则,患者被视为散发性 MS。我们比较了不同代亲属之间的发病年龄,并比较了家族性和散发性 MS 的发病年龄。

结果

发现年轻一代的发病年龄更低(中位数 22 岁 vs. 30 岁,P<0.001),家族性 MS 与散发性 MS 相比,疾病的发病年龄显著更低(中位数 25 岁 vs. 29 岁,P=0.042)。

结论

家族性 MS 年轻一代的 MS 发病年龄提前,家族性 MS 比散发性 MS 的发病年龄更低。

相似文献

1
Anticipation of age at onset in familial multiple sclerosis.家族性多发性硬化症发病年龄的预测。
Eur J Neurol. 2010 Apr;17(4):572-5. doi: 10.1111/j.1468-1331.2009.02870.x. Epub 2009 Dec 7.
2
Progression in familial and nonfamilial MS.家族性和非家族性多发性硬化症的进展
Mult Scler. 2008 Apr;14(3):300-6. doi: 10.1177/1352458507084269. Epub 2008 Jan 21.
3
Disease onset in familial and sporadic multiple sclerosis in Argentina.阿根廷家族性和散发性多发性硬化症的疾病发作情况。
Mult Scler Relat Disord. 2016 Mar;6:54-56. doi: 10.1016/j.msard.2016.01.004. Epub 2016 Jan 19.
4
Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients.与门诊患者相比,在多发性硬化症中心接受随访的患者更早出现残疾。
Mult Scler. 2009 Feb;15(2):251-7. doi: 10.1177/1352458508097919.
5
Earlier age of symptom onset in younger generation of familial cases of multiple sclerosis.多发性硬化症家族病例中青年一代发病年龄更早。
Neurol Sci. 2024 Sep;45(9):4463-4469. doi: 10.1007/s10072-024-07512-w. Epub 2024 Apr 9.
6
Disease onset in familial and sporadic primary progressive multiple sclerosis.家族性和散发性原发性进行性多发性硬化症的发病。
Mult Scler. 2010 Jun;16(6):694-700. doi: 10.1177/1352458510367661. Epub 2010 Apr 8.
7
Anticipation of age at onset in multiple sclerosis: methodologic pitfalls.多发性硬化症发病年龄的预测:方法学陷阱。
Acta Neurol Scand. 2010 Jun;121(6):426-8. doi: 10.1111/j.1600-0404.2009.01273.x.
8
Factors associated with the risk of secondary progression in multiple sclerosis.与多发性硬化症继发进展风险相关的因素。
Mult Scler. 2008 Jul;14(6):799-803. doi: 10.1177/1352458508089361. Epub 2008 Jun 23.
9
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population.多发性硬化症风险:撒丁岛人群中人类白细胞抗原与环境之间的相互作用
Mult Scler. 2009 Sep;15(9):1030-6. doi: 10.1177/1352458509106745. Epub 2009 Jul 22.
10
Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation.家族性慢性骨髓增殖性疾病:临床表型与疾病早现的证据
J Clin Oncol. 2007 Dec 10;25(35):5630-5. doi: 10.1200/JCO.2007.12.6896. Epub 2007 Nov 12.

引用本文的文献

1
Adaptive and Innate Immunity Are Key Drivers of Age at Onset of Multiple Sclerosis.适应性免疫和先天性免疫是多发性硬化症发病年龄的关键驱动因素。
Neurol Genet. 2024 May 29;10(3):e200159. doi: 10.1212/NXG.0000000000200159. eCollection 2024 Jun.
2
Earlier age of symptom onset in younger generation of familial cases of multiple sclerosis.多发性硬化症家族病例中青年一代发病年龄更早。
Neurol Sci. 2024 Sep;45(9):4463-4469. doi: 10.1007/s10072-024-07512-w. Epub 2024 Apr 9.
3
Comparing Clinical and Radiological Features in Familial and Sporadic Multiple Sclerosis.
家族性和散发性多发性硬化症的临床与放射学特征比较
Cureus. 2023 Sep 1;15(9):e44504. doi: 10.7759/cureus.44504. eCollection 2023 Sep.
4
Mitochondrial DNA haplogroup analysis in Saudi Arab patients with multiple sclerosis.沙特阿拉伯多发性硬化症患者的线粒体 DNA 单倍群分析。
PLoS One. 2022 Dec 19;17(12):e0279237. doi: 10.1371/journal.pone.0279237. eCollection 2022.
5
Epidemiology of familial multiple sclerosis in Iran: a national registry-based study.伊朗家族性多发性硬化症的流行病学:基于国家登记的研究。
BMC Neurol. 2022 Mar 5;22(1):76. doi: 10.1186/s12883-022-02609-1.
6
The global prevalence of familial multiple sclerosis: an updated systematic review and meta-analysis.家族性多发性硬化症的全球患病率:一项更新的系统评价和荟萃分析。
BMC Neurol. 2021 Jun 28;21(1):246. doi: 10.1186/s12883-021-02267-9.
7
Multiple sclerosis in Iran: An epidemiological update with focus on air pollution debate.伊朗的多发性硬化症:聚焦空气污染争议的流行病学最新情况
J Clin Transl Res. 2021 Feb 17;7(1):49-60. eCollection 2021 Feb 25.
8
Predictors of Multiple Sclerosis Severity Score in Patients with Multiple Sclerosis.多发性硬化症患者多发性硬化症严重程度评分的预测因素
Int J MS Care. 2020 Sep-Oct;22(5):233-238. doi: 10.7224/1537-2073.2019-054. Epub 2020 Jan 13.
9
Familial multiple sclerosis and association with other autoimmune diseases.家族性多发性硬化症与其他自身免疫性疾病的关联。
Brain Behav. 2017 Dec 19;8(1):e00899. doi: 10.1002/brb3.899. eCollection 2018 Jan.
10
Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999-2015.伊朗多发性硬化症家族复发患病率上升:基于德黑兰1999 - 2015年登记处的一项人群研究。
BMC Neurol. 2018 Feb 7;18(1):15. doi: 10.1186/s12883-018-1019-2.